Exploring the diagnosis and management of HFpEF in general practice

The diagnosis and management of heart failure with preserved ejection fraction (HFpEF) has been significantly updated as a result of the 2022 Australian consensus statement on heart failure. This update, as well as recent TGA approval, means that Australian patients now have access to the latest recommended pharmacological treatment for HFpEF.

In this webinar you will learn how to diagnose HFpEF and distinguish it from heart failure with reduced ejection fraction (HFrEF) or heart failure with mildly reduced ejection fraction (HFmrEF). Our expert speakers will also discuss pharmacological and non-pharmacological treatment options for HFpEF, including practical management steps to ensure optimal outcomes for your patients.

Presenters: DrDr Shane Nanayakkara and A/Prof Ralph Audehm

Click here for more information and to register.